Documents & Downloads

CPT2

CRC Prognostic Biomarker

CPT2 (Carnitine palmitoyltransferase 2) is an enzyme involved in fatty acid oxidation and serves as a prognostic biomarker for colorectal cancer (CRC). Overexpression of CPT2 activates phosphorylated p53, leading to increased p53 levels, which inhibits tumor proliferation and promotes apoptosis. Its deficiency is associated with inherited disorders affecting long-chain fatty acid oxidation in skeletal muscle. Additionally, decreased levels of CPT2 correlate with the progression of various cancers, highlighting its potential significance in cancer research.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	1670277-66-3
Applications	CRC Prognostic Biomarker
Synonyms	Carnitine palmitoyltransferase 2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.